Skip Navigation

This Article
Right arrow Print PDF (514K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (105)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Wang, R. Y.-H.
Right arrow Articles by Ehrlich, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, R. Y.-H.
Right arrow Articles by Ehrlich, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1980, Vol. 8, No. 20 4777-4790
© 1980

CHEMISTRY

Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues

Richard Y.-H. Wang*, Charles W. Gehrke+ and Melanie Ehrlich*

*Department of Biochemistry, Tulane Medical School New Orleans, LA 70112, USA +Department of Biochemistry, Experiment Station Chemical Laboratories, University of Missouri Columbia, MO 65201, USA

Received August 4, 1980. Sodium bisulfite is a mutagen which can specifically deaminate more than 96% of the cytosine residues in single-stranded DNA via formation of a 5,6-dihydrocytosine-6-sulfonate intermediate. Under the same reaction conditions, only 2–3% of the 5-methylcytosine (m5Cyt) residues in single-stranded XP-12 DNA, which has 34 mole% m5Cyt was converted to thymine (Thy) residues. In contrast, at the deoxynucleoside and free base levels, the same treatment with bisulfite and then alkali converted 51% and > 95%, respectively, of the m5Cyt to the corresponding Thy derivatives. However, the rate of reaction of m5Cyt and its deoxyribonucleoside was much slower than that of the analogous quantitative conversion of cytosine or deoxycytidine to uracil or deoxyuridine, respectively. The much lower reactivity of m5Cyt and its derivatives compared to that of the unmethylated analogs is primarily due to a decrease in the rate of formation of the sulfonate adduct.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Mol. Diagn.Home page
K. S. Gustafson
Locked Nucleic Acids Can Enhance the Analytical Performance of Quantitative Methylation-Specific Polymerase Chain Reaction
J. Mol. Diagn., January 1, 2008; 10(1): 33 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Munson, J. Clark, K. Lamparska-Kupsik, and S. S. Smith
Recovery of bisulfite-converted genomic sequences in the methylation-sensitive QPCR
Nucleic Acids Res., May 14, 2007; 35(9): 2893 - 2903.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
N. Umetani, M. F.G. de Maat, E. Sunami, S. Hiramatsu, S. Martinez, and D. S.B. Hoon
Methylation of p16 and Ras Association Domain Family Protein 1a during Colorectal Malignant Transformation
Mol. Cancer Res., May 1, 2006; 4(5): 303 - 309.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
M. Bibikova, Z. Lin, L. Zhou, E. Chudin, E. W. Garcia, B. Wu, D. Doucet, N. J. Thomas, Y. Wang, E. Vollmer, et al.
High-throughput DNA methylation profiling using universal bead arrays
Genome Res., March 1, 2006; 16(3): 383 - 393.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Yegnasubramanian, X. Lin, M. C. Haffner, A. M. DeMarzo, and W. G. Nelson
Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation
Nucleic Acids Res., February 9, 2006; 34(3): e19 - e19.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Dote, D. Cerna, W. E. Burgan, D. J. Carter, M. A. Cerra, M. G. Hollingshead, K. Camphausen, and P. J. Tofilon
Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine
Clin. Cancer Res., June 15, 2005; 11(12): 4571 - 4579.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Noguchi, K. Tanimoto, T. Shimokuni, K. Ukon, H. Tsujimoto, M. Fukushima, T. Noguchi, K. Kawahara, K. Hiyama, and M. Nishiyama
Aberrant Methylation of DPYD Promoter, DPYD Expression, and Cellular Sensitivity to 5-Fluorouracil in Cancer Cells
Clin. Cancer Res., October 15, 2004; 10(20): 7100 - 7107.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Dote, S. Toyooka, K. Tsukuda, M. Yano, M. Ouchida, H. Doihara, M. Suzuki, H. Chen, J.-T. Hsieh, A. F. Gazdar, et al.
Aberrant Promoter Methylation in Human DAB2 Interactive Protein (hDAB2IP) Gene in Breast Cancer
Clin. Cancer Res., March 15, 2004; 10(6): 2082 - 2089.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
Q N Vo, J Geradts, M L Gulley, D A Boudreau, J C Bravo, and B G Schneider
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation
J. Clin. Pathol., September 1, 2002; 55(9): 669 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. O. Toyooka, S. Toyooka, A. Maitra, Q. Feng, N. C. Kiviat, A. Smith, J. D. Minna, R. Ashfaq, and A. F. Gazdar
Establishment and Validation of Real-Time Polymerase Chain Reaction Method for CDH1 Promoter Methylation
Am. J. Pathol., August 1, 2002; 161(2): 629 - 634.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Curradi, A. Izzo, G. Badaracco, and N. Landsberger
Molecular Mechanisms of Gene Silencing Mediated by DNA Methylation
Mol. Cell. Biol., May 1, 2002; 22(9): 3157 - 3173.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. Deng, G. Deng, M. F. Smith, J. Zhou, H. Xin, S. M. Powell, and Y. Lu
Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography
Nucleic Acids Res., February 1, 2002; 30(3): e13 - e13.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Sun, G. Jiang, M.-A. A. Zaydan, V. F. La Russa, H. Safah, and M. Ehrlich
ABL1 Promoter Methylation Can Exist Independently of BCR-ABL Transcription in Chronic Myeloid Leukemia Hematopoietic Progenitors
Cancer Res., September 1, 2001; 61(18): 6931 - 6937.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. Grunau, S. J. Clark, and A. Rosenthal
Bisulfite genomic sequencing: systematic investigation of critical experimental parameters
Nucleic Acids Res., July 1, 2001; 29(13): e65 - e65.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Worm, A. Aggerholm, and P. Guldberg
In-Tube DNA Methylation Profiling by Fluorescence Melting Curve Analysis
Clin. Chem., July 1, 2001; 47(7): 1183 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. O. Toyooka, S. Toyooka, A. K. Virmani, U. G. Sathyanarayana, D. M. Euhus, M. Gilcrease, J. D. Minna, and A. F. Gazdar
Loss of Expression and Aberrant Methylation of the CDH13 (H-Cadherin) Gene in Breast and Lung Carcinomas
Cancer Res., June 1, 2001; 61(11): 4556 - 4560.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S.-i. Mizuno, T. Chijiwa, T. Okamura, K. Akashi, Y. Fukumaki, Y. Niho, and H. Sasaki
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia
Blood, March 1, 2001; 97(5): 1172 - 1179.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. K. Ying, H. H. Hassanain, C. M. Roos, D. J. Smiraglia, J.-P. J. Issa, R. E. Michler, M. Caligiuri, C. Plass, and P. J. Goldschmidt-Clermont
Methylation of the estrogen receptor-{alpha} gene promoter is selectively increased in proliferating human aortic smooth muscle cells
Cardiovasc Res, April 1, 2000; 46(1): 172 - 179.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. K. Dessain, H.-y. Yu, R. R. Reddel, R. L. Beijersbergen, and R. A. Weinberg
Methylation of the Human Telomerase Gene CpG Island
Cancer Res., February 1, 2000; 60(3): 537 - 541.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. J. Jang and L. Mao
Methylation Patterns in Human Androgen Receptor Gene and Clonality Analysis
Cancer Res., February 1, 2000; 60(4): 864 - 866.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. M. Venkataraman, M. Yatin, R. Marcinek, and K. B. Ain
Restoration of Iodide Uptake in Dedifferentiated Thyroid Carcinoma: Relationship to Human Na+/I- Symporter Gene Methylation Status
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2449 - 2457.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. Aggerholm, P. Guldberg, M. Hokland, and P. Hokland
Extensive Intra- and Interindividual Heterogeneity of p15INK4B Methylation in Acute Myeloid Leukemia
Cancer Res., January 1, 1999; 59(2): 436 - 441.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Rein, D. A. Natale, U. Gartner, M. Niggemann, M. L. DePamphilis, and H. Zorbas
Absence of an Unusual "Densely Methylated Island" at the Hamster dhfr ori-beta
J. Biol. Chem., April 11, 1997; 272(15): 10021 - 10029.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M Ehrlich and R. Wang
5-Methylcytosine in eukaryotic DNA
Science, June 19, 1981; 212(4501): 1350 - 1357.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.